The reported incidence of deep-vein thrombosis in hospital patients varies from less than 1 % (Barker et al., 1940 ; Felder, 1949) to over 28% (Sevitt and Gallagher, 1959) . This wide variation reflects not only differences in the populations at risk but also differences in the criteria of diagnosis and in the vigilance with which they are sought. There is general agreement that the clinical diagnosis of deep-vein thrombosis may be difficult or impossible, and the occurrence of pulmonary embolism without previous recognition of its cause is common experience. The usually accepted signs of deep-vein thrombosis are oedema, calf tenderness on pressure or on dorsiflex on of the ankle, and tenderness over the femoral vein. Some authors add cyanosis of the limb and dilated superficial veins, and a few mention raised temperature of the affected limb. Delayed cooling on exposure of the limb as an early sign of venous thrombosis was first mentioned by Pilcher (1939) , who stated, "I do not remember any patient showing this sign who did not develop others " (of deep-vein thrombosis).
This paper reports an attempt to assess the value of this physical sign. The investigation was planned to answer three questions: (1) What other factors than deep-vein thrombosis can cause delayed cooling on exposure ? (2) In the absence of such factors is delayed cooling a reliable early sign of deep-vein thrombosis ? (3) Is delayed cooling always followed by other physical signs of deep-vein thrombosis ?
Patients During a period of six months 514 patients in an adult male and an adult female ward were examined in the manner described below, 3,950 observations being made. The patients comprised a group of general surgical cases, including emergencies and cold surgery, together with some thoracic and vascular cases. Orthopaedic and genito-urinary cases were not usually resident in these wards and only a few are included in the series. Eight of the 28 beds in the male ward were occupied by patients receiving radiotherapy for malignant disease. Many of these were ill and confined to bed. Patients with dressings or bandages on the legs were excluded.
Method
Each patient was examined at least every other day, th._ majority every day. The patient being supine, both legs were extended with the feet wide apart and uncovered to above the knee. Particular care was taken to ensure that the legs were not crossed and that the pat-ent was not lying on his side, and to see that there was no constriction of the thighs by clothing. The legs were thus exposed for about 10 minutes, after which the observer, using one hand, relt the skin around both ankles and noted any difference of temperature. 
Deep-vein Thi
The varicose-vein group is probably abnormally small because many patients were admitted in the evening for operation the next morning. They were therefore often in the theatre or premedicated when the round was done. Of the 17 patients with ischaemic limbs it was not always the more affected leg which was the cooler. Gangrenous changes with mild infection often made this leg warmer. The varicose group always showed the affected leg to be warmer ; with bilateral varicose veins the worse-affected leg was usually warmer. The other causes, with the exception of the two patients having an intravenous infusion into one leg, also gave a warmer leg on the affected side. This group of 40 patients may seem large in comparison with the other groups in Table I , but the wards contained many patients with arterial insufficiency in the legs and varicose veins.
The following more detailed analysis concerns only the 36 patients in Table I which males predominated because of the inclusion of the radiotherapy cases, there were nine men and three women, and the right leg was found to be warmer seven times. Effect of Operation.- Table V shows the incidence of warm legs in those patients undergoing operation. The group of operated patients was divided into three subgroups by the severity of their operation. It can be seen that there were far hiore warm legs in the major group. Thrombosis.-The Chart shows the time at which warm legs and clinical signs of deep-vein thrombosis were first noted in the overall group and in those patients who had operations. There are two apparent waves in the warm-leg series-one soon after admiss on or operation (these are not necessarily the same), and the other, wider, wave occurring at 5 to 10 days, when the incidence of deep-vein thrombosis might be expected to be at its highest. The patients with clinical deep-vein thrombosis did not apparently show this same trend in the two groups, but this may be because the numbers in the deepvein-thrombosis group are much smaller. It was noted in the 36 patients who had unexplained warm legs that 14 had a warm leg only and 14 had a warm leg before developing the clinical signs of deep-vein thrombosis in the same leg, whereas only three patients had signs of deep-vein thrombosis in one leg before showing an ipsilateral warm leg. In five patients a warm leg and signs of deep-vein thrombosis were observed together at the first examination. Table VI shows these relations in the operated and non-operated groups. The period of time which elapsed between the onset of warm leg and the appearance of the signs of deep-vein thrombosis varied. It was one to six days in the non-operated group, the interval being one day in four instances, and two and seven days in The common site for the beginning of deep-vein thrombosis is the calf muscles (Gibbs, 1957) , whence it may or may not spread to the main deep veins of the limb. It is only when such spread occurs that the full clinical picture with oedema and thigh tenderness will develop. The structure of pulmonary emboli suggests that the propagation and separation of the clot is often rapid, and many believe that when the signs of thrombosis are gross embolization is less likely. The stage at which diagnosis is needed is while thrombosis is confined to the calf and before occlusion of main deep veins has occurred.
As an explanation of delayed cooling on exposure it is postulated that thrombosis in deep veins results in shunting of the venous return into superficial veins and that increased flow in these raises skin temperature. The presence of dilated veins below the knee has been noted by other observers (Homans, 1934 ; Felder, 1949) in association with deep-vein thrombosis. Such dilated veins are most easily recognized in thin subjects, but many patients with deep-vein thrombosis are fat. A rise of skin temperature has also been noted by Homans (1934 ), Felder (1949 , and Short (1952 The statistical evidence given does not prove that the relation between a warm leg and deep venous thrombosis is causal, but in the absence of any other suggested factor it seems very likely to be so. Additional support for the theory is given by the relation of the sign of a warm leg to age, time of onset, and type of operation. This conforms closely to the findings of Barker et al. (1940 Barker et al. ( , 1941 at the Mayo Clinic for deep venous thrombosis.
The finding of warm legs from days 1 to 3 after admission is in keeping with the evidence of Browse (1964) that hospitalization alone increases the period of a patient's inactivity from 33 % to 63 % per 24 hours. It may also increase his tendency to venous thrombosis at that time.
The number of pulmonary emboli in the series is too small for any conclusions to be drawn, but, using a warm leg with or without the generally accepted signs as evidence of thrombosis, the diagnosed incidence of deep venous thrombosis in this series (including those patients without a warm leg) is 10.500. If patients with a warm leg only are excluded the incidence of deep venous thrombosis falls to 7.3 It remains to be seen how often pulmonary embolism follows the finding of a warm leg alone.
Summary
A clinical investigation is described of delayed cooling (warm leg) as an early physical sign of unilateral deep venous thrombosis of the lower extremities in 468 patients. Thirty-six of them had an otherwise inexplicable unilateral warm leg, and statistical analysis of these patients shows that there is a highly significant correlation between the presence of a warm leg and the signs of venous thrombosis in that leg. The same statistical correlation is present when these patients are subdivided for age and type of operation, and the results are more significant in patients undergoing major operations and in patients over the age of 59 years. of angina pectoris in a double-blind trial (Prichard, Dickinson, Alleyne, Hurst, Hill, Rosenheim, and Laurence, 1963) . Its use in angina was, however, discontinued following a report of its tumour-producing activity in mice (Paget, 1963) . A further disadvantage of pronethalol was that the therapeutic dose was close to that which produced side-effects.
Black, Crowther, Shanks, Smith, and Dornhorst (1964) have described the pharmacology of propranolol (Inderal), a betareceptor-blocking agent in animals and man with about ten times the potency of pronethalol. It is non-carcinogenic in mice and other experimental animals. In view of the effectiveness of pronethalol it was thought that the closely related drug propranolol might be of value in angina. The present paper reports a double-blind trial in out-patients with angina pectoris.
Design of Trial
The design of the trial closely followed that described by Prichard et ad. (1963) . The original aim was to compare maximum tolerated doses of propranolol with placebo, but this was modified in that an upper dose limit of 100 mg. q.d.s. was later fixed ; this dose represented 40 tablets a day. During the " run-in period" the initial dosage was 10 mg. q.d.s. Increments of 10 mg. per dose per week were made up either to 100 mg. q.d.s. or to the maximum tolerated dose, when this was less. This variable dosage was selected because of the need to take into account individual variability, and also because benefit at a lower dosage might be largely a placebo effect, which may also result from increased frequency of out-patient visits. This latter factor was mitigated by having a long run-in period before the trial proper, three months or more, a period further extended owing to delay in obtaining identically tasting placebo tablets. During this time patients were seen every two weeks and the dosage was adjusted.
The period of the actual trial was eight weeks. Patients were given placebo and propranolol each for two periods of two weeks' duration; they were identical in taste and appearance. Randomization of these four periods was made so that the six possible orders were achieved for every six patients admitted to the trial.
Patients were considered suitable for admission to the trial if they were having at least two typical attacks of angina pectoris each week. The pain had to be of characteristic nature, site, and radiation, brought on by exertion, relieved by rest and glyceryl trinitrate, and usually lasting for one to three minutes. The purpose of the trial was explained to the patients, who were told that the new drug would be compared with identical dummy tablets in order to try to eliminate bias. Sixteen patients were started on the run-in period. One 71-year-old woman developed signs and symptoms of heart failure two days after starting 10 mg. q.d.s. The drug was stopped; the symptoms cleared without further treatment in three days, as previously reported by Prichard and Gillam (1964 
Assessment
Patients were asked to take glyceryl trinitrate for pain, but not prophylactically, and to record their attacks of angina and glyceryl trinitrate consumption on record sheets that were provided. The sheets were divided into four periods for each day, and patients were asked to fill in their sheet at the end of each period, to record the time of onset of angina, its duration, severity, and the number of glyceryl trinitrate tablets consumed, and to note any comments they desired. Patients were supplied with a known number of tablets, and those taken from the bottle were checked with the number recorded as consumed.
Patients were seen fortnightly by the same clinicians at each visit. The physician who assessed each patient did not know whether propranolol or placebo was being taken and did not refer to previous assessment sheets. Patients were asked standard questions and their subjective impressions recorded.
Results
The results are summarized in Table I . All 14 patients consumed fewer glyceryl trinitrate tablets and had fewer attacks of pain on propranolol than on placebo. The probability that all 14 patients should produce the same result due to chance is P = 0.00012, which is highly significant. The subjective reports of the patients were assessed as +2 (much better), + 1 (better), 0 (same), -1 (worse), -2 (much worse). The score on placebo was subtracted from that on the drug so that a positive score indicated subjective benefit from propranolol. The maximum score in any patient depended on the number of changes between drug and placebo, which was determined by the
